HOME Top Market Reports HLA Typing for Transplant Market by Technology (SSO-PCR, SSP-PCR, NGS, Sanger’s Sequencing), Products & Services (Instruments, Reagents, Software), Application (Diagnostics, Research), End User (Hospitals, Academia, Diagnostic Center) - Forecast to 2021

HLA Typing for Transplant Market by Technology (SSO-PCR, SSP-PCR, NGS, Sanger’s Sequencing), Products & Services (Instruments, Reagents, Software), Application (Diagnostics, Research), End User (Hospitals, Academia, Diagnostic Center) - Forecast to 2021

By: marketsandmarkets.com
Publishing Date: May 2016
Report Code: MD 3686

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global HLA typing for transplant market is projected to reach USD 753.9 Million by 2021 from USD 535.0 Million in 2016, at a CAGR of 7.1% from 2016 to 2021. Market growth can be attributed to factors such as the rising number of solid organ, soft tissue, and stem cell transplantations; technological advancements in the field of organ transplantation; increased funding, research grants, and public-private investments; technological shift from serological assays to gene-based HLA profiling; and improving healthcare infrastructure across developing countries.

In 2016, North America and Europe are expected to be the mature markets for HLA typing products for transplant. However, emerging regions such as Asia-Pacific (including Japan, China, and India) are expected to become the new revenue-generating pockets in the HLA typing for transplant market in the next five years. The North America is expected to hold the largest share of the global HLA typing for transplant market in 2016; it is projected to grow at the highest CAGR during the forecast period owing to easy accessibility and high adoption of advanced diagnostic technologies (such as PCR and NGS) among healthcare professionals, increasing prevalence of target diseases (such as cancer, heart failure, and renal diseases) in the U.S. and Canada, and continuous technological advancements in the field of HLA-based transplant diagnostics.

Europe is expected to hold the second-largest share of the global HLA typing for transplant market in 2016. This leading market position of the European market is due to factors such as rising acceptance of genome-based diagnostic techniques by healthcare professionals, large number of organ transplantation procedures performed annually, presence of a large number of biotechnology and molecular diagnostic companies, and rapid growth in the aging population.

Thermo Fisher Scientific, Inc. (U.S.) dominated the global HLA typing for transplant market with a share of 42.0% in 2015. In the past three years, the company adopted strategic acquisitions and geographic expansions as key growth strategies to maintain its dominant position in the global transplant diagnostics market. Other leading players present in the HLA typing for transplant market are Immucor, Inc. (U.S), Olerup SSp AB (Sweden), QIAGEN, Inc. (Netherlands), Bio-Rad Laboratories, Inc. (U.S.), Affymetrix, Inc. (U.S.), Illumina Inc. (U.S.), Luminex Corporation, (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), and Abbott Laboratories, Inc. (U.S.), among others.

Target Audience

  •  HLA-based Transplant Diagnostic Product Manufacturing Companies
  • Healthcare Service Providers (Including Hospitals and Transplant Centers)
  • Research and Development (R&D) Companies
  • Commercial Service Providers
  • Diagnostic Laboratories
  • Clinical Research Organizations (CROs)
  • Research Laboratories and Academic Institutes
  • Market Research and Consulting Firms

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This research report categorizes the HLA typing for transplant market into the following segments and sub segments:

HLA Typing for Transplant Market, By Technology

  • Non-Molecular Assay
    • Serological Assay
    • Mixed Lymphocyte Culture Assay (MLC Assay)
  • Molecular Assay
    • PCR-based
      • Sequence specific primer-PCR (SSP-PCR)
      • Sequence specific oligonucleotide-PCR (SSO-PCR)
    • Sequencing-based
      • Next Generation Sequencing
      • Sanger’s Sequencing

HLA Typing for Transplant Market, By Products and Services

  • Instruments
  • Reagents and Consumables
  • Software and Services

HLA Typing for Transplant Market, By Application

  • Diagnostic Applications
  • Research Applications

HLA Typing for Transplant Market, By End-User

  • Hospitals and Transplant Centers
  • Research Laboratories and Academic Institutions
  • Commercial Service Providers

HLA Typing for Transplant Market, By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Rest of Europe (RoE)
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the global HLA typing for transplant market report:

Product Analysis

  • Product Matrix which gives a detailed comparison of the product portfolios of the top five companies

Geographical Analysis

  • Further breakdown of the Rest of Europe HLA typing for transplant market into Poland, Italy, Spain, and other countries
  • Further breakdown of the RoW HLA typing for transplant market into the Middle East, Latin America, and Africa

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 17)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Geographic Scope
           1.3.3 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 21)
    2.1 Research Data
           2.1.1 Secondary Data
                     2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                     2.1.2.1 Key Data From Primary Sources
                     2.1.2.2 Breakdown of Primaries
    2.2 Opportunity Indicators
           2.2.1 Introduction
           2.2.2 Demand-Side Analysis
                     2.2.2.1 Healthcare Expenditure Patterns
                     2.2.2.2 Rapid Growth in Geriatric Population
                     2.2.2.3 Rising Incidence and Prevalence of Cancer
                     2.2.2.4 Growing Burden of Cardiovascular Diseases (CVDS)
                     2.2.2.5 Increasing Number of Organ Donations and Transplantations
           2.2.3 Supply-Side Analysis
                     2.2.3.1 Number of New Product Launches: HLA-Based Transplant Diagnostics vs Competitive Technologies
                     2.2.3.2 Parent Market Analysis: Immunoassay Market
    2.3 Market Size Estimation
           2.3.1 Bottom-Up Approach
           2.3.2 Top-Down Approach
    2.4 Market Breakdown and Data Triangulation
    2.5 Research Assumptions
           2.5.1 Assumptions

3 Executive Summary (Page No. - 42)
    3.1 Introduction
    3.2 Current Scenario
    3.3 Future Outlook
    3.4 Conclusion

4 Premium Insights (Page No. - 49)
    4.1 Global Market Overview
    4.2 Global HLA-Based Transplant Diagnostic Technology Market, By Region (2016)
    4.3 Global HLA-Based Transplant Diagnostics Product and Services Market, By Region (2016-2021)
    4.4 Global HLA Typing for Transplant Applications Market, By Region (2016-2021)
    4.5 Global Market, By End User (2016–2021)
    4.6 Global Market, By Country (2016–2021)

5 Market Overview (Page No. - 54)
    5.1 Introduction
    5.2 Market Segmentation
    5.3 Market Dynamics
           5.3.1 Key Market Drivers
                     5.3.1.1 Growing Number of Solid Organ, Soft-Tissue, and Stem Cell Transplantation Procedures
                     5.3.1.2 Technological Advancements in the Field of HLA Typing
                     5.3.1.3 Increased Funding, Research Grants, and Public-Private Investments
           5.3.2 Key Market Restraints
                     5.3.2.1 High Cost of NGS and PCR-Based Devices
                     5.3.2.2 Limited Medical Reimbursements for Organ Donation and Transplantation Procedures
           5.3.3 Key Market Opportunities
                     5.3.3.1 Technological Shift From Serological Assays to Gene-Based HLA Profiling
                     5.3.3.2 Improving Healthcare Infrastructure Across Developing Countries
           5.3.4 Key Market Challenges
                     5.3.4.1 Significant Gap Between Number of Organs Donated and Organs Required Annually

6 Industry Insights (Page No. - 64)
    6.1 Introduction
    6.2 Value Chain Analysis
    6.3 Industry Trends
           6.3.1 Integration of Advanced Technologies With Molecular Assay Procedure
    6.4 Porter’s Five Forces Analysis
           6.4.1 Threat of New Entrants
           6.4.2 Threat of Substitutes
           6.4.3 Bargaining Power of Suppliers
           6.4.4 Bargaining Power of Buyers
           6.4.5 Intensity of Competitive Rivalry

7 HLA Typing for Transplant Market, By Technology (Page No. - 70)
    7.1 Introduction
    7.2 Molecular Assays
           7.2.1 PCR-Based Molecular Assays
                     7.2.1.1 Sequence-Specific Primer (SSP)-PCR
                     7.2.1.2 Sequence-Specific Oligonucleotide (SSO)-PCR
           7.2.2 Sequencing-Based Molecular Assays
                     7.2.2.1 Sanger Sequencing
                     7.2.2.2 Next-Generation Sequencing (NGS)
    7.3 Non-Molecular Assays
           7.3.1 Serological Assays
           7.3.2 Mixed Lymphocyte Culture (MLC) Assays

8 Market, By Products & Services (Page No. - 83)
    8.1 Introduction
    8.2 Reagents and Consumables
    8.3 Instruments
    8.4 Software and Services

9 HLA Typing for Transplant Market, By Application (Page No. - 88)
    9.1 Introduction
    9.2 Diagnostic Applications
    9.3 Research Applications

10 Market, By End User (Page No. - 93)
     10.1 Introduction
     10.2 Hospitals and Transplant Centers
     10.3 Commercial Service Providers
     10.4 Research Laboratories and Academic Institutes

11 HLA Typing for Transplant Market, By Region (Page No. - 99)
     11.1 Introduction
     11.2 North America
               11.2.1 U.S.
               11.2.2 Canada
     11.3 Europe
               11.3.1 Germany
               11.3.2 U.K.
               11.3.3 France
               11.3.4 Rest of Europe (RoE)
     11.4 Asia-Pacific
               11.4.1 Japan
               11.4.2 China
               11.4.3 India
               11.4.4 Rest of Asia-Pacific (RoAPAC)
     11.5 Rest of the World (RoW)

12 Competitive Landscape (Page No. - 129)
     12.1 Overview
     12.2 Market Share Analysis
     12.3 Competitive Scenario
     12.4 Recent Developments
               12.4.1 Agreements, Partnerships, and Collaborations
               12.4.2 New Product Launches, Approvals, and Product Enhancements
               12.4.3 Strategic Acquisitions
               12.4.4 Geographic Expansions

13 Company Profiles (Page No. - 137)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     13.1 Introduction
     13.2 Thermo Fisher Scientific, Inc.
     13.3 Immucor, Inc.
     13.4 Olerup SSP AB
     13.5 Qiagen N.V.
     13.6 Bio-Rad Laboratories, Inc.
     13.7 Illumina, Inc.
     13.8 Affymetrix, Inc.
     13.9 F. Hoffmann-LA-Roche Limited
     13.10 Luminex Corporation
     13.11 Abbott Laboratories, Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 175)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.4 Introducing RT : Real-Time Market Intelligence
     14.5 Available Customizations
     14.6 Related Reports


List of Tables (79 Tables)

Table 1 Total Cost of Transplant Procedures in the U.S.: By Organ Transplantation Stages (Including Transplant Diagnosis and Monitoring)
Table 2 Global Market Size, By Technology, 2014-2021 (USD Million)
Table 3 Global Market Size for Molecular Assays, By Type, 2014-2021 (USD Million)
Table 4 Market Size for Molecular Assays, By Region, 2014-2021 (USD Million)
Table 5 Global Market Size for PCR-Based Molecular Assays, By Type, 2014-2021 (USD Million)
Table 6 Market Size for PCR-Based Molecular Assays, By Region, 2014-2021 (USD Million)
Table 7 Market Size for SSP-PCR-Based Molecular Assays, By Region, 2014-2021 (USD Million)
Table 8 Market Size for SSO-PCR-Based Molecular Assays, By Region, 2014-2021 (USD Million)
Table 9 Global Market Size for Sequencing-Based Molecular Assays, By Type, 2014-2021 (USD Million)
Table 10 Market Size for Sequencing-Based Molecular Assays, By Region, 2014-2021 (USD Million)
Table 11 Market Size for Sanger Sequencing, By Region, 2014-2021 (USD Million)
Table 12 Market Size for NGS, By Region, 2014-2021 (USD Million)
Table 13 Market Size for Non-Molecular Assays, By Type, 2014-2021 (USD Million)
Table 14 Market Size for Non-Molecular Assays, By Region, 2014-2021 (USD Million)
Table 15 Market Size for Serological Assays, By Region, 2014-2021 (USD Million)
Table 16 Market Size for MLC Assays, By Region, 2014-2021 (USD Million)
Table 17 Global Market Size, By Products & Services, 2014-2021 (USD Million)
Table 18 HLA-Based Transplant Diagnostic Reagents and Consumables Market Size, By Region, 2014-2021 (USD Million)
Table 19 HLA-Based Transplant Diagnostic Instruments Market Size, By Region, 2014-2021 (USD Million)
Table 20 HLA-Based Transplant Diagnostic Software and Services Market Size, By Region, 2014-2021 (USD Million)
Table 21 Global Market Size, By Application, 2014-2021 (USD Million)
Table 22 HLA-Based Transplant Diagnostics Market Size for Diagnostic Applications, By Region, 2014-2021 (USD Million)
Table 23 HLA-Based Transplant Diagnostics Market Size for Research Applications, By Region, 2014-2021 (USD Million)
Table 24 Global Market Size, By End User, 2014–2021 (USD Million)
Table 25 HLA-Based Transplant Diagnostics Market Size for Hospitals and Transplant Centers, By Region, 2014–2021 (USD Million)
Table 26 HLA-Based Transplant Diagnostics Market Size for Commercial Service Providers, By Region, 2014–2021 (USD Million)
Table 27 HLA-Based Transplant Diagnostics Market Size for Research Laboratories and Academic Institutes, By Region, 2014–2021 (USD Million)
Table 28 Market Size, By Region, 2014-2021 (USD Million)
Table 29 North America: Market Size, By Country, 2014-2021
Table 30 U.S.: Market Size, By Technology, 2014-2021 (USD Million)
Table 31 U.S.: Market Size, By Products & Services, 2014-2021 (USD Million)
Table 32 U.S.: Market Size, By Application, 2014-2021 (USD Million)
Table 33 U.S.: Market Size, By End User, 2014-2021 (USD Million)
Table 34 Canada: Market Size, By Technology, 2014-2021 (USD Million)
Table 35 Canada: Market Size, By Products & Services, 2014-2021 (USD Million)
Table 36 Canada: Market Size, By Application, 2014-2021 (USD Million)
Table 37 Canada: Market Size, By End User, 2014-2021 (USD Million)
Table 38 Europe: Market Size, By Country, 2014-2021 (USD Million)
Table 39 Germany: Market Size, By Technology, 2014-2021 (USD Million)
Table 40 Germany: Market Size, By Products & Services, 2014-2021 (USD Million)
Table 41 Germany: Market Size, By Application, 2014-2021 (USD Million)
Table 42 Germany: Market Size, By End User, 2014-2021
Table 43 U.K.: Market Size, By Technology, 2014-2021 (USD Million)
Table 44 U.K.: Market Size, By Products & Services, 2014-2021 (USD Million)
Table 45 U.K.: Market Size, By Application, 2014-2021 (USD Million)
Table 46 U.K.: Market Size, By End User, 2014-2021 (USD Million)
Table 47 France: Market Size, By Technology, 2014-2021 (USD Million)
Table 48 France: Market Size, By Products & Services, 2014-2021 (USD Million)
Table 49 France: Market Size, By Application, 2014-2021 (USD Million)
Table 50 France: Market Size, By End User, 2014-2021 (USD Million)
Table 51 RoE: Market Size, By Technology, 2014-2021 (USD Million)
Table 52 RoE: Market Size, By Products & Services, 2014-2021 (USD Million)
Table 53 RoE: Market Size, By Application, 2014-2021 (USD Million)
Table 54 RoE: Market Size, By End User, 2014-2021 (USD Million)
Table 55 Asia-Pacific: Market Size, By Country, 2014-2021 (USD Million)
Table 56 Japan: Market Size, By Technology, 2014-2021 (USD Million)
Table 57 Japan: Market Size, By Products & Services, 2014-2021 (USD Million)
Table 58 Japan: Market Size, By Application, 2014-2021 (USD Million)
Table 59 Japan: Market Size, By End User, 2014-2021 (USD Million)
Table 60 China: Market Size, By Technology, 2014-2021 (USD Million)
Table 61 China: Market Size, By Products & Services, 2014-2021 (USD Million)
Table 62 China: Market Size, By Application, 2014-2021 (USD Million)
Table 63 China: Market Size, By End User, 2014-2021 (USD Million)
Table 64 India: Market Size, By Technology, 2014-2021 (USD Million)
Table 65 India: Market Size, By Products & Services, 2014-2021 (USD Million)
Table 66 India: Market Size, By Application, 2014-2021 (USD Million)
Table 67 India: Market Size, By End User, 2014-2021 (USD Million)
Table 68 RoAPAC: Market Size, By Technology, 2014-2021 (USD Million)
Table 69 RoAPAC: Market Size, By Products & Services, 2014-2021 (USD Million)
Table 70 RoAPAC: Market Size, By Application, 2014-2021 (USD Million)
Table 71 RoAPAC: Market Size, By End User, 2014-2021 (USD Million)
Table 72 RoW: Market Size, By Technology, 2014-2021 (USD Million)
Table 73 RoW: Market Size, By Products & Services, 2014-2021 (USD Million)
Table 74 RoW: Market Size, By Application, 2014-2021 (USD Million)
Table 75 RoW: Market Size, By End User, 2014-2021 (USD Million)
Table 76 Top Agreements, Partnerships, and Collaborations, 2012–2016
Table 77 Top New Product Launches, Approvals, and Product Enhancements, 2012–2016
Table 78 Top Strategic Acquisitions, 2012–2016
Table 79 Top Geographical Expansions, 2012–2016
 

List of Figures (60 Figures)
 
Figure 1 Research Design
Figure 2 Healthcare Expenditure Across Major Countries: 2000–2013
Figure 3 Healthcare Expenditure Across Major Regions: 2000–2013
Figure 4 Healthcare Spending Matrix: Key Markets (2013)
Figure 5 Increase in Geriatric Population, By Country (2011–2030)
Figure 6 Increase in the Proportion of the Elderly in the Overall Population, By Country (2011–2030)
Figure 7 Percentage Increase in Geriatric Population, By Region  (1980–2010 vs 2010–2040)
Figure 8 Global Burden of Cancer, By Region (2005–2030)
Figure 9 Number of New Cancer Cases, By Country (2012–2020)
Figure 10 Increasing Incidence of Various Cancers, 2008–2020
Figure 11 Global Burden of Cardiovascular Diseases, By Region (2005–2030)
Figure 12 Number of Living and Deceased Organ Donations, By Country  (2010–2014)
Figure 13 Number of New Product Launches: HLA-Based Transplant Diagnostic Assay vs Competitive Modalities, 2012–2015
Figure 14 Molecular Assay-Based HLA Typing Technology is Expected to Be the Fastest-Growing Immunoassay Technology By 2021
Figure 15 Bottom-Up Approach: HLA-Based Transplant Diagnostics Instruments Market
Figure 16 Bottom-Up Approach: HLA-Based Transplant Diagnostic Reagents and Consumables Market
Figure 17 Top-Down Approach
Figure 18 Data Triangulation
Figure 19 Assumptions of the Research Study
Figure 20 Global HLA Typing for Transplant Market Size, By Technology, 2016 vs 2021
Figure 21 Geographic Analysis: HLA Typing for Transplant Market, By Products & Services, 2016
Figure 22 Geographic Analysis: HLA Typing for Transplant Market Size, By Application, 2016 vs 2021
Figure 23 Global HLA Typing for Transplant Market Size, By End User, 2016 vs 2021
Figure 24 HLA Typing for Transplant Market Share, By Region, 2016
Figure 25 Growing Number of Transplantation Procedures to Drive the Market Growth for HLA-Based Transplant Diagnostics
Figure 26 North America is Expected to Dominate the HLA Typing for Transplant Market, By Technology, in 2016
Figure 27 Reagents and Consumables to Dominate the HLA-Based Transplant Diagnostics Products Market During the Forecast Period
Figure 28 North America is Expected to Command the Largest Share of HLA Typing for Transplant Diagnostic Applications Market in 2016
Figure 29 Hospitals and Transplant Centers to Dominate the HLA Typing for Transplant Market During the Forecast Period
Figure 30 U.S. and Germany are Expected to Dominate the Global HLA-Based Transplant Diagnostics Market Till 2021
Figure 31 HLA Typing for Transplant Market: Drivers, Restraints, Opportunities, and Challenges
Figure 32 Number of Organ Transplant Procedures, 2010–2013
Figure 33 Percentage Change in Annual Healthcare Expenditure—Developed vs Developing Countries (2010–2013)
Figure 34 Value Chain Analysis: Major Value is Added to the Overall Product Pricing During R&D Phase
Figure 35 Porter’s Five Forces Analysis: HLA Typing for Transplant Market (2015)
Figure 36 Growing Adoption of PCR- and NGS-Based Products is Propelling Revenue Growth for Molecular Assays Market
Figure 37 NGS-Based Devices are Expected to Form the Fastest-Growing Molecular Assay Technology Segment Till 2021
Figure 38 Serological Assay Technique is Expected to Witness Positive Market Growth During 2016-2021
Figure 39 Reagents and Consumables Segment to Dominate the HLA-Based Transplant Diagnostics Market During 2016–2021
Figure 40 Diagnostic Applications Segment to Dominate the Market During the Forecast Period
Figure 41 The Hospitals & Transplant Centers End-User Segment is Expected to Dominate the HLA Typing for Transplant Market in 2016
Figure 42 U.S. and Germany to Grow at the Highest Rates in the HLA-Based Transplant Diagnostics Market
Figure 43 North American HLA Typing for Transplant Market Snapshot: 2016-2021
Figure 44 European HLA Typing for Transplant Market Snapshot: 2016-2021
Figure 45 Asia-Pacific HLA Typing for Transplant Market Snapshot: 2016-2021
Figure 46 RoW HLA-Based Transplant Diagnostics Market Snapshot: 2016-2021
Figure 47 Agreements, Partnerships, and Collaborations: Key Growth Strategy Adopted By A Majority of Market Players From 2012 to 2016
Figure 48 Global HLA-Based Transplant Diagnostics Market Share, Key Player, 2015
Figure 49 Growing Number of Agreements, Partnerships, and Collaborations is Stimulating Market Competition Among Key Products Manufacturers
Figure 50 Geographic Revenue Mix of the Top 5 Market Players* (2015)
Figure 51 Capacity Building and Capability Enhancement: A Key Growth Strategy Adopted By Major Market Players
Figure 52 Thermo Fisher Scientific, Inc.: Company Snapshot
Figure 53 Immucor, Inc.: Company Snapshot
Figure 54 Qiagen N.V.: Company Snapshot
Figure 55 Bio-Rad Laboratories, Inc.: Company Snapshot
Figure 56 Illumina, Inc.: Company Snapshot
Figure 57 Affymetrix, Inc.: Company Snapshot
Figure 58 F. Hoffmann-LA-Roche Ltd: Company Snapshot
Figure 59 Luminex Corporation: Company Snapshot
Figure 60 Abbott Laboratories, Inc.: Company Snapshot

The global HLA typing for transplant market is projected to reach USD 753.9 Million by 2021 from USD 535.0 Million in 2016, growing at a CAGR of 7.1% from 2016 to 2021. Market growth can be attributed to factors such as the rising number of solid organ, soft tissue, and stem cell transplantations; technological advancements in the field of organ transplantations; and increased funding, research grants, and public-private investments. However, the high device costs associated with NGS and PCR-based devices and limited medical reimbursements for organ donation and transplantation procedures restrain the optimal growth of the HLA typing for transplant market.

On the basis of products and services, the HLA typing for transplant market is segmented into reagents and consumables, instruments, and software & services. The reagents and consumables segment is expected to account for the largest share of the global market in 2016. Reagents and consumables are the fastest-growing product segment, growing at a double-digit CAGR during 2016 to 2021. Market growth of the reagents and consumables segment is propelled by factors such as long-term sales contracts signed by market players with major end users, expanding applications of molecular assay techniques in HLA typing, increasing marker preference for HLA typing in organ transplantation, rising number of organ transplantation procedures across major markets (such as the U.S., Germany, the U.K., Japan, China, and India), and growing utilization of HLA typing in research. The instruments segment is expected to hold the second-largest share of the global HLA typing for transplant market in 2016. The dominant market position of the HLA-based transplant diagnostic instruments segment is mainly due to factors such as ongoing technological advancements in the field of HLA typing (such as device automation and commercialization of NGS instruments), increasing awareness regarding the benefits of genome-based HLA typing as compared to serological assays, and increasing adoption of PCR and NGS instruments among CROs, transplant centers, and hospitals.

On the basis of applications, the global HLA typing for transplant market is segmented into diagnostic and research applications. The diagnostic applications segment is expected to account for the larger share of the global market in 2016. The diagnostic applications segment is also projected to grow faster as compared to research applications in the global HLA typing for transplant market during 2016–2021. The significant growth potential of the diagnostic applications segment can be attributed to factors such as the rising number of solid organ transplantations, increasing installation base of PCR & sequencing-based devices, growing adoption of HLA profiling among hospitals and transplant centers, and rising awareness among public related to the benefits of molecular assay-based procedures. The research applications segment is expected to witness a positive market growth during the study period due to factors such as increasing public–private investments that support genomics-based transplantation research, growing use of robotics in laboratory automation, and growing number of PCR and NGS-based clinical trials.

HLA Typing for Transplant Market

Geographically, the HLA typing for transplant market is classified into four regions North America, Europe, Asia-Pacific, and the Rest of the World. North America and Europe are mature markets for HLA-based transplant diagnostic products. However, emerging regions such as Asia-Pacific (including Japan, China, and India, among others) are expected to become new revenue-generating pockets in the HLA typing for transplant market in the next five years. The North America is expected to hold the largest share of the global market in 2016; it is projected to grow at the highest CAGR during the forecast period owing to easy accessibility and high adoption of advanced diagnostic technologies (such as PCR and NGS) among healthcare professionals, increasing prevalence of target diseases (such as cancer, heart failure, and renal diseases) in the U.S. and Canada, and continuous technological advancements in the field of HLA-based transplant diagnostics.

Product development & commercialization and agreements, collaborations, and partnerships were the key growth strategies adopted by prominent players to strengthen their global positioning in the market. Moreover, strategies such as mergers, acquisitions, and geographic expansions were also adopted by a significant number of market players to strengthen their product portfolios and expand their distribution networks in the global HLA typing for transplant market during 2012–2015.

As of 2015, the key players in the HLA typing for transplant market included Thermo Fischer Scientific, Inc. (U.S.), Immucor, Inc. (U.S), Olerup SSp AB (Sweden), QIAGEN, Inc. (Netherlands), Bio-Rad Laboratories, Inc. (U.S.), Affymetrix, Inc. (U.S.), Illumina Inc. (U.S.), Luminex Corporation, (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), and Abbott Laboratories, Inc. (U.S.), among others.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth In-Vitro Diagnostics Markets on KnowledgeStore
Request Demo